Connect Biopharma Holdings Ltd ADR (CNTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2022 | 12-2021 | 06-2021 | 12-2020 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 141,366 | 267,716 | 313,470 | 154,803 |
| Marketable Securities | 49,270 | 0 | N/A | 2,003 |
| Receivables | 7,127 | 7,412 | 11,285 | 5,160 |
| TOTAL | $197,763 | $275,128 | $324,755 | $161,966 |
| Non-Current Assets | ||||
| PPE Net | 11,148 | 10,219 | 4,373 | 1,474 |
| Investments And Advances | 22,303 | 0 | 0 | 0 |
| Other Non-Current Assets | 914 | 3,038 | 4,318 | 3,096 |
| TOTAL | $34,365 | $13,257 | $8,691 | $4,570 |
| Total Assets | $234,696 | $291,052 | $336,485 | $166,267 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 15,142 | 12,735 | 10,159 | 3,776 |
| Other current liabilities | 5,281 | 5,152 | 3,774 | 1,955 |
| TOTAL | $20,649 | $17,985 | $14,028 | $5,824 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 317,477 |
| TOTAL | $1,053 | $810 | $75 | $317,524 |
| Total Liabilities | $21,702 | $18,795 | $14,103 | $323,348 |
| Shareholders' Equity | ||||
| Common Shares | 10 | 10 | 10 | 4 |
| Retained earnings | -414,138 | -373,004 | -311,732 | -164,193 |
| Other shareholders' equity | 17,050 | 3,057 | 631 | 753 |
| TOTAL | $212,994 | $272,257 | $322,382 | $-157,081 |
| Total Liabilities And Equity | $234,696 | $291,052 | $336,485 | $166,267 |